Health Canada drug identification number

DIN 02385279 — TERBINAFINE 250 MG

TERBINAFINE is a tablet of Terbinafine marketed by SIVEM PHARMACEUTICALS ULC. The full Terbinafine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02385279
Brand name
TERBINAFINE
Active ingredient
Terbinafine
Strength
250 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
SIVEM PHARMACEUTICALS ULC
Health Canada status
MARKETED
Drug class
Allylamine antifungal agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Terbinafine products

DINBrandStrengthFormManufacturerStatus
02239893 APO-TERBINAFINE 250 MG TABLET APOTEX INC MARKETED
02320134 AURO-TERBINAFINE 250 MG TABLET AURO PHARMA INC MARKETED
02031094 LAMISIL 1 % CREAM NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02238703 LAMISIL 1 % SPRAY NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02294273 PMS-TERBINAFINE 250 MG TABLET PHARMASCIENCE INC MARKETED
02353121 TERBINAFINE 250 MG TABLET SANIS HEALTH INC DORMANT
02242735 TERBINAFINE-250 250 MG TABLET PRO DOC LIMITEE MARKETED
02254727 TEVA-TERBINAFINE 250 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.